C4 Therapeutics Q1 2026 Earnings Strong EPS Beat Highlights Cost Discipline Amid PreRevenue Stage Acacia Research Corporation ACTG Q1 2026 Earnings Significant EPS Miss Amidst Uncertain Revenue Landscape Immunovant Q1 2026 Earnings Wider Than Expected Loss Amid No Revenue STVN Q1 2026 Earnings EPS Surpasses Estimates by Over 5 VLGEA Q1 2025 Earnings Profitability Holds Steady Amidst Challenging Retail Environment Pixelworks Inc PXLW Q1 2026 Earnings Massive EPS Surprise Amid Revenue Disclosure Gap